Liver Fat in the Metabolic Syndrome
Background: The liver, once fatty, overproduces components of the metabolic syndrome, such as glucose and lipids. The amount of liver fat in subjects with and without the metabolic syndrome has not been determined. It is unknown which clinically available markers best reflect liver fat content. Meas...
Saved in:
Published in | The journal of clinical endocrinology and metabolism Vol. 92; no. 9; pp. 3490 - 3497 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Bethesda, MD
Oxford University Press
01.09.2007
Endocrine Society |
Subjects | |
Online Access | Get full text |
ISSN | 0021-972X 1945-7197 |
DOI | 10.1210/jc.2007-0482 |
Cover
Abstract | Background: The liver, once fatty, overproduces components of the metabolic syndrome, such as glucose and lipids. The amount of liver fat in subjects with and without the metabolic syndrome has not been determined. It is unknown which clinically available markers best reflect liver fat content.
Measurements: Components of the metabolic syndrome as defined by the International Diabetes Federation and liver fat content by proton magnetic resonance spectroscopy were measured in 271 nondiabetic subjects (162 women, 109 men). In addition, other features of insulin resistance (serum insulin, C-peptide), intraabdominal and sc fat by magnetic resonance imaging, and liver enzymes (serum alanine aminotransferase and serum aspartate aminotransferase) were measured.
Results: Liver fat was 4-fold higher in subjects with [n = 116; median 8.2% (interquartile range 3.2–18.7%)] than without [n = 155; 2.0% (1.0–5.0%); P < 0.0001] the metabolic syndrome. This increase in liver fat remained significant after adjusting for age, gender, and body mass index. All components of the metabolic syndrome correlated with liver fat content. The best correlate was waist in both women (r = 0.59, P < 0.0001) and men (r = 0.56, P < 0.0001). Liver fat correlated significantly with serum alanine aminotransferase (r = 0.39, P < 0.0001 for women; r = 0.44, P < 0.0001 for men) and aspartate aminotransferase (r = 0.27, P = 0.0005 for women; r = 0.31, P = 0.0012 for men) concentrations. The best correlates of liver fat were fasting serum insulin (r = 0.61; P < 0.0001 for both women and men) and C-peptide (r = 0.62; P < 0.0001 for both women and men).
Conclusions: Liver fat content is significantly increased in subjects with the metabolic syndrome as compared with those without the syndrome, independently of age, gender, and body mass index. Of other markers, serum C-peptide is the strongest correlate of liver fat. |
---|---|
AbstractList | The liver, once fatty, overproduces components of the metabolic syndrome, such as glucose and lipids. The amount of liver fat in subjects with and without the metabolic syndrome has not been determined. It is unknown which clinically available markers best reflect liver fat content.
Components of the metabolic syndrome as defined by the International Diabetes Federation and liver fat content by proton magnetic resonance spectroscopy were measured in 271 nondiabetic subjects (162 women, 109 men). In addition, other features of insulin resistance (serum insulin, C-peptide), intraabdominal and sc fat by magnetic resonance imaging, and liver enzymes (serum alanine aminotransferase and serum aspartate aminotransferase) were measured.
Liver fat was 4-fold higher in subjects with [n = 116; median 8.2% (interquartile range 3.2-18.7%)] than without [n = 155; 2.0% (1.0-5.0%); P < 0.0001] the metabolic syndrome. This increase in liver fat remained significant after adjusting for age, gender, and body mass index. All components of the metabolic syndrome correlated with liver fat content. The best correlate was waist in both women (r = 0.59, P < 0.0001) and men (r = 0.56, P < 0.0001). Liver fat correlated significantly with serum alanine aminotransferase (r = 0.39, P < 0.0001 for women; r = 0.44, P < 0.0001 for men) and aspartate aminotransferase (r = 0.27, P = 0.0005 for women; r = 0.31, P = 0.0012 for men) concentrations. The best correlates of liver fat were fasting serum insulin (r = 0.61; P < 0.0001 for both women and men) and C-peptide (r = 0.62; P < 0.0001 for both women and men).
Liver fat content is significantly increased in subjects with the metabolic syndrome as compared with those without the syndrome, independently of age, gender, and body mass index. Of other markers, serum C-peptide is the strongest correlate of liver fat. The liver, once fatty, overproduces components of the metabolic syndrome, such as glucose and lipids. The amount of liver fat in subjects with and without the metabolic syndrome has not been determined. It is unknown which clinically available markers best reflect liver fat content.BACKGROUNDThe liver, once fatty, overproduces components of the metabolic syndrome, such as glucose and lipids. The amount of liver fat in subjects with and without the metabolic syndrome has not been determined. It is unknown which clinically available markers best reflect liver fat content.Components of the metabolic syndrome as defined by the International Diabetes Federation and liver fat content by proton magnetic resonance spectroscopy were measured in 271 nondiabetic subjects (162 women, 109 men). In addition, other features of insulin resistance (serum insulin, C-peptide), intraabdominal and sc fat by magnetic resonance imaging, and liver enzymes (serum alanine aminotransferase and serum aspartate aminotransferase) were measured.MEASUREMENTSComponents of the metabolic syndrome as defined by the International Diabetes Federation and liver fat content by proton magnetic resonance spectroscopy were measured in 271 nondiabetic subjects (162 women, 109 men). In addition, other features of insulin resistance (serum insulin, C-peptide), intraabdominal and sc fat by magnetic resonance imaging, and liver enzymes (serum alanine aminotransferase and serum aspartate aminotransferase) were measured.Liver fat was 4-fold higher in subjects with [n = 116; median 8.2% (interquartile range 3.2-18.7%)] than without [n = 155; 2.0% (1.0-5.0%); P < 0.0001] the metabolic syndrome. This increase in liver fat remained significant after adjusting for age, gender, and body mass index. All components of the metabolic syndrome correlated with liver fat content. The best correlate was waist in both women (r = 0.59, P < 0.0001) and men (r = 0.56, P < 0.0001). Liver fat correlated significantly with serum alanine aminotransferase (r = 0.39, P < 0.0001 for women; r = 0.44, P < 0.0001 for men) and aspartate aminotransferase (r = 0.27, P = 0.0005 for women; r = 0.31, P = 0.0012 for men) concentrations. The best correlates of liver fat were fasting serum insulin (r = 0.61; P < 0.0001 for both women and men) and C-peptide (r = 0.62; P < 0.0001 for both women and men).RESULTSLiver fat was 4-fold higher in subjects with [n = 116; median 8.2% (interquartile range 3.2-18.7%)] than without [n = 155; 2.0% (1.0-5.0%); P < 0.0001] the metabolic syndrome. This increase in liver fat remained significant after adjusting for age, gender, and body mass index. All components of the metabolic syndrome correlated with liver fat content. The best correlate was waist in both women (r = 0.59, P < 0.0001) and men (r = 0.56, P < 0.0001). Liver fat correlated significantly with serum alanine aminotransferase (r = 0.39, P < 0.0001 for women; r = 0.44, P < 0.0001 for men) and aspartate aminotransferase (r = 0.27, P = 0.0005 for women; r = 0.31, P = 0.0012 for men) concentrations. The best correlates of liver fat were fasting serum insulin (r = 0.61; P < 0.0001 for both women and men) and C-peptide (r = 0.62; P < 0.0001 for both women and men).Liver fat content is significantly increased in subjects with the metabolic syndrome as compared with those without the syndrome, independently of age, gender, and body mass index. Of other markers, serum C-peptide is the strongest correlate of liver fat.CONCLUSIONSLiver fat content is significantly increased in subjects with the metabolic syndrome as compared with those without the syndrome, independently of age, gender, and body mass index. Of other markers, serum C-peptide is the strongest correlate of liver fat. Background: The liver, once fatty, overproduces components of the metabolic syndrome, such as glucose and lipids. The amount of liver fat in subjects with and without the metabolic syndrome has not been determined. It is unknown which clinically available markers best reflect liver fat content. Measurements: Components of the metabolic syndrome as defined by the International Diabetes Federation and liver fat content by proton magnetic resonance spectroscopy were measured in 271 nondiabetic subjects (162 women, 109 men). In addition, other features of insulin resistance (serum insulin, C-peptide), intraabdominal and sc fat by magnetic resonance imaging, and liver enzymes (serum alanine aminotransferase and serum aspartate aminotransferase) were measured. Results: Liver fat was 4-fold higher in subjects with [n = 116; median 8.2% (interquartile range 3.2–18.7%)] than without [n = 155; 2.0% (1.0–5.0%); P < 0.0001] the metabolic syndrome. This increase in liver fat remained significant after adjusting for age, gender, and body mass index. All components of the metabolic syndrome correlated with liver fat content. The best correlate was waist in both women (r = 0.59, P < 0.0001) and men (r = 0.56, P < 0.0001). Liver fat correlated significantly with serum alanine aminotransferase (r = 0.39, P < 0.0001 for women; r = 0.44, P < 0.0001 for men) and aspartate aminotransferase (r = 0.27, P = 0.0005 for women; r = 0.31, P = 0.0012 for men) concentrations. The best correlates of liver fat were fasting serum insulin (r = 0.61; P < 0.0001 for both women and men) and C-peptide (r = 0.62; P < 0.0001 for both women and men). Conclusions: Liver fat content is significantly increased in subjects with the metabolic syndrome as compared with those without the syndrome, independently of age, gender, and body mass index. Of other markers, serum C-peptide is the strongest correlate of liver fat. Background: The liver, once fatty, overproduces components of the metabolic syndrome, such as glucose and lipids. The amount of liver fat in subjects with and without the metabolic syndrome has not been determined. It is unknown which clinically available markers best reflect liver fat content. Measurements: Components of the metabolic syndrome as defined by the International Diabetes Federation and liver fat content by proton magnetic resonance spectroscopy were measured in 271 nondiabetic subjects (162 women, 109 men). In addition, other features of insulin resistance (serum insulin, C-peptide), intraabdominal and sc fat by magnetic resonance imaging, and liver enzymes (serum alanine aminotransferase and serum aspartate aminotransferase) were measured. Results: Liver fat was 4-fold higher in subjects with [n = 116; median 8.2% (interquartile range 3.2–18.7%)] than without [n = 155; 2.0% (1.0–5.0%); P < 0.0001] the metabolic syndrome. This increase in liver fat remained significant after adjusting for age, gender, and body mass index. All components of the metabolic syndrome correlated with liver fat content. The best correlate was waist in both women (r = 0.59, P < 0.0001) and men (r = 0.56, P < 0.0001). Liver fat correlated significantly with serum alanine aminotransferase (r = 0.39, P < 0.0001 for women; r = 0.44, P < 0.0001 for men) and aspartate aminotransferase (r = 0.27, P = 0.0005 for women; r = 0.31, P = 0.0012 for men) concentrations. The best correlates of liver fat were fasting serum insulin (r = 0.61; P < 0.0001 for both women and men) and C-peptide (r = 0.62; P < 0.0001 for both women and men). Conclusions: Liver fat content is significantly increased in subjects with the metabolic syndrome as compared with those without the syndrome, independently of age, gender, and body mass index. Of other markers, serum C-peptide is the strongest correlate of liver fat. |
Author | Yki-Järvinen, Hannele Westerbacka, Jukka Bergholm, Robert Pietiläinen, Kirsi H. Kotronen, Anna |
Author_xml | – sequence: 1 givenname: Anna surname: Kotronen fullname: Kotronen, Anna organization: 1 Department of Medicine (A.K., J.W., R.B., K.H.P., H.Y.-J.), Department of Psychiatry, University of Helsinki, FIN-00029 Helsinki, Finland – sequence: 2 givenname: Jukka surname: Westerbacka fullname: Westerbacka, Jukka organization: 1 Department of Medicine (A.K., J.W., R.B., K.H.P., H.Y.-J.), Department of Psychiatry, University of Helsinki, FIN-00029 Helsinki, Finland – sequence: 3 givenname: Robert surname: Bergholm fullname: Bergholm, Robert organization: 1 Department of Medicine (A.K., J.W., R.B., K.H.P., H.Y.-J.), Department of Psychiatry, University of Helsinki, FIN-00029 Helsinki, Finland – sequence: 4 givenname: Kirsi H. surname: Pietiläinen fullname: Pietiläinen, Kirsi H. organization: 1 Department of Medicine (A.K., J.W., R.B., K.H.P., H.Y.-J.), Department of Psychiatry, University of Helsinki, FIN-00029 Helsinki, Finland – sequence: 5 givenname: Hannele surname: Yki-Järvinen fullname: Yki-Järvinen, Hannele email: ykijarvi@cc.helsinki.fi organization: 1 Department of Medicine (A.K., J.W., R.B., K.H.P., H.Y.-J.), Department of Psychiatry, University of Helsinki, FIN-00029 Helsinki, Finland |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19081800$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/17595248$$D View this record in MEDLINE/PubMed |
BookMark | eNp10U1LAzEQBuAgFVs_bp5loagXVyfZbD6OIlaFigcVvIVsNosp201NdoX-e7e2Kogehrk8M8zw7qJB4xuL0CGGc0wwXMzMOQHgKVBBttAIS5qnHEs-QCMAglPJycsQ7cY4A8CU5tkOGmKey5xQMULjqXu3IZnoNnFN0r7a5N62uvC1M8njsimDn9t9tF3pOtqDTd9Dz5Prp6vbdPpwc3d1OU1NxmWbcqCMVQBGaEnB5ERKKrVmJUButc5KUghSMGYlEaSklmNeVBiIpqwgDFfZHjpZ710E_9bZ2Kq5i8bWtW6s76JiglCWg-jh-Bec-S40_W0qw4zSvoD06mijumJuS7UIbq7DUn0934PjDdDR6LoKujEu_jgJAguA3pG1M8HHGGyljGt163zTBu1qhUGtklAzo1ZJqFUS_dDZr6HvvX_z0zX33eI_-Rlx9gFMsZCp |
CODEN | JCEMAZ |
CitedBy_id | crossref_primary_10_1016_j_jhep_2009_02_031 crossref_primary_10_3390_nu14030716 crossref_primary_10_1080_14728222_2020_1728742 crossref_primary_10_1161_CIR_0b013e318233bc6a crossref_primary_10_1016_j_trsl_2017_10_009 crossref_primary_10_1093_cid_ciz435 crossref_primary_10_1097_MCO_0b013e32833ec41b crossref_primary_10_3390_ijms24021090 crossref_primary_10_1038_nrgastro_2016_147 crossref_primary_10_1016_j_nutres_2012_06_012 crossref_primary_10_2337_dc07_1463 crossref_primary_10_1186_s12887_015_0378_8 crossref_primary_10_1111_apha_12253 crossref_primary_10_1002_nbm_2837 crossref_primary_10_1002_oby_20114 crossref_primary_10_1002_hep_32519 crossref_primary_10_1111_apt_14499 crossref_primary_10_1016_j_jbc_2021_100714 crossref_primary_10_3390_genes11111243 crossref_primary_10_1016_j_dld_2015_08_004 crossref_primary_10_1016_j_jhepr_2021_100322 crossref_primary_10_1016_j_expneurol_2021_113725 crossref_primary_10_3390_nu15234870 crossref_primary_10_1017_S0029665121003761 crossref_primary_10_1002_hep4_1070 crossref_primary_10_1016_j_mam_2016_11_008 crossref_primary_10_1007_s11883_022_00996_x crossref_primary_10_3389_fphar_2022_910789 crossref_primary_10_14218_JCTH_2019_00030 crossref_primary_10_1016_S2213_8587_14_70032_4 crossref_primary_10_5812_hepatmon_35055 crossref_primary_10_3390_ijms22126642 crossref_primary_10_3350_cmh_2021_0371 crossref_primary_10_3390_ijms17050633 crossref_primary_10_1155_2021_6620289 crossref_primary_10_23736_S2724_5985_22_03139_4 crossref_primary_10_1093_ajcn_88_1_16 crossref_primary_10_1038_bmt_2010_144 crossref_primary_10_1089_met_2017_0058 crossref_primary_10_1210_en_2012_1390 crossref_primary_10_3748_wjg_14_3476 crossref_primary_10_1016_j_jhep_2009_05_023 crossref_primary_10_1136_postgradmedj_2013_201620rep crossref_primary_10_1016_j_clinre_2014_08_014 crossref_primary_10_1016_j_jhep_2016_09_022 crossref_primary_10_3945_ajcn_112_038695 crossref_primary_10_1016_j_exger_2013_05_059 crossref_primary_10_1186_1471_2458_10_237 crossref_primary_10_1016_j_diabet_2018_11_003 crossref_primary_10_1016_j_jhep_2008_12_025 crossref_primary_10_1515_CCLM_2010_302 crossref_primary_10_2196_17110 crossref_primary_10_1093_eurheartj_ehr453 crossref_primary_10_1177_1756283X11405251 crossref_primary_10_1016_S1665_2681_19_31484_X crossref_primary_10_1097_MD_0000000000040417 crossref_primary_10_1210_clinem_dgaf094 crossref_primary_10_1016_j_ijcard_2013_06_024 crossref_primary_10_1186_s12902_021_00758_x crossref_primary_10_3109_07853890_2010_532152 crossref_primary_10_1586_eem_10_5 crossref_primary_10_3390_jcm10030390 crossref_primary_10_1016_j_ctim_2024_103018 crossref_primary_10_1111_j_1440_1746_2010_06509_x crossref_primary_10_1016_j_diabres_2024_111609 crossref_primary_10_1007_s00125_013_2829_9 crossref_primary_10_1007_s11377_016_0063_y crossref_primary_10_3390_nu11122871 crossref_primary_10_4103_jod_jod_17_21 crossref_primary_10_1111_j_1365_2893_2010_01394_x crossref_primary_10_3390_biomedicines11061595 crossref_primary_10_1038_oby_2010_291 crossref_primary_10_1152_ajpendo_00272_2010 crossref_primary_10_1136_bmj_m4747 crossref_primary_10_1007_s13340_020_00448_4 crossref_primary_10_1016_j_cmet_2011_06_007 crossref_primary_10_1155_2015_535982 crossref_primary_10_1186_1475_2840_9_30 crossref_primary_10_1007_s11901_016_0295_9 crossref_primary_10_1038_s41598_017_13209_2 crossref_primary_10_1210_jc_2017_02751 crossref_primary_10_1177_0003319715576672 crossref_primary_10_1016_j_jnutbio_2015_12_005 crossref_primary_10_2478_v10255_012_0019_z crossref_primary_10_1530_EJE_16_0608 crossref_primary_10_1371_journal_pone_0221524 crossref_primary_10_3390_ijms17091554 crossref_primary_10_1016_j_expneurol_2018_04_004 crossref_primary_10_1530_EJE_10_0186 crossref_primary_10_3389_fendo_2022_866189 crossref_primary_10_1016_j_numecd_2008_12_007 crossref_primary_10_1111_eci_13878 crossref_primary_10_1111_j_1365_2036_2008_03896_x crossref_primary_10_1016_j_livres_2022_05_005 crossref_primary_10_1039_c2mb25115a crossref_primary_10_5812_hepatmon_37388 crossref_primary_10_1155_2016_5251738 crossref_primary_10_3892_etm_2013_1090 crossref_primary_10_1136_jclinpath_2013_201620 crossref_primary_10_1016_j_hfc_2012_06_010 crossref_primary_10_1160_TH13_06_0499 crossref_primary_10_17352_ahr_000004 crossref_primary_10_1177_1756283X11403809 crossref_primary_10_1038_s41598_017_14706_0 crossref_primary_10_1136_bmjgast_2021_000817 crossref_primary_10_1155_2012_716404 crossref_primary_10_1016_j_jhep_2010_04_008 crossref_primary_10_1007_s00246_012_0447_9 crossref_primary_10_1016_j_fct_2012_04_039 crossref_primary_10_1111_j_1478_3231_2011_02526_x crossref_primary_10_1080_13697130802447074 crossref_primary_10_7861_clinmedicine_15_6_s77 crossref_primary_10_18553_jmcp_2020_26_6_775 crossref_primary_10_1111_cen_12758 crossref_primary_10_14814_phy2_12661 crossref_primary_10_1053_j_gastro_2008_03_021 crossref_primary_10_1007_s11695_023_07014_2 crossref_primary_10_1155_2021_6696473 crossref_primary_10_1177_21501319241247974 crossref_primary_10_1007_s10620_013_2957_6 crossref_primary_10_3390_biomedicines11030663 crossref_primary_10_1053_j_gastro_2010_06_064 crossref_primary_10_1016_j_ijcard_2013_07_230 crossref_primary_10_1038_nrgastro_2010_41 crossref_primary_10_1002_hep_26342 crossref_primary_10_3851_IMP2039 crossref_primary_10_3390_jcm11051375 crossref_primary_10_1152_ajpendo_00444_2007 crossref_primary_10_1002_oby_22432 crossref_primary_10_1097_MCO_0b013e32833f4b34 crossref_primary_10_2147_DMSO_S314935 crossref_primary_10_1017_S0007114510002187 crossref_primary_10_1016_j_dld_2014_09_020 crossref_primary_10_1093_bja_aev199 crossref_primary_10_1097_CRD_0000000000000537 crossref_primary_10_1016_j_nutres_2013_09_002 crossref_primary_10_1586_17474124_2015_1056156 crossref_primary_10_14218_JCTH_2019_00010 crossref_primary_10_1016_j_hbpd_2021_06_002 crossref_primary_10_2478_inmed_2019_0052 crossref_primary_10_1007_s00125_008_1135_4 crossref_primary_10_1161_ATVBAHA_112_300075 crossref_primary_10_3390_antiox10101546 crossref_primary_10_1016_j_jhep_2010_05_037 crossref_primary_10_1210_jc_2007_1825 crossref_primary_10_1111_jdi_12107 crossref_primary_10_1186_1741_7015_9_85 crossref_primary_10_1016_j_bbadis_2018_09_013 crossref_primary_10_1016_j_metabol_2016_06_009 crossref_primary_10_3390_nu7115454 crossref_primary_10_1210_jc_2008_1245 crossref_primary_10_1016_j_atherosclerosis_2015_07_018 crossref_primary_10_1016_j_cgh_2008_11_023 crossref_primary_10_1016_S1262_3636_08_74600_7 crossref_primary_10_1038_oby_2010_137 crossref_primary_10_1016_j_cca_2008_07_024 crossref_primary_10_7759_cureus_41959 crossref_primary_10_1007_s11695_023_06804_y crossref_primary_10_17656_jsmc_10094 crossref_primary_10_1152_ajpgi_00074_2008 crossref_primary_10_4166_kjg_2013_62_6_344 crossref_primary_10_1038_ejcn_2010_27 crossref_primary_10_2217_clp_12_47 crossref_primary_10_3390_nu14173452 crossref_primary_10_3390_ijms21165888 crossref_primary_10_1016_j_jhep_2010_07_029 crossref_primary_10_1016_j_bbalip_2015_12_019 crossref_primary_10_1089_met_2012_0169 crossref_primary_10_1038_ijo_2010_40 crossref_primary_10_1111_joim_20032 crossref_primary_10_4162_nrp_2017_11_2_105 crossref_primary_10_1038_ijo_2012_181 crossref_primary_10_1210_jc_2017_00867 crossref_primary_10_1515_HMBCI_2010_002 crossref_primary_10_1016_j_physbeh_2007_11_049 crossref_primary_10_1017_S0029665118002653 crossref_primary_10_1371_journal_pone_0032213 crossref_primary_10_2217_clp_11_68 crossref_primary_10_1016_j_dld_2010_01_016 crossref_primary_10_1002_dmrr_2888 crossref_primary_10_1007_s40267_013_0043_y crossref_primary_10_1186_s13098_019_0408_z crossref_primary_10_1038_oby_2011_152 crossref_primary_10_1136_gutjnl_2017_313884 crossref_primary_10_17826_cumj_407589 crossref_primary_10_37349_emed_2020_00019 crossref_primary_10_5812_hepatmon_33155 crossref_primary_10_1007_s12072_013_9430_7 crossref_primary_10_1007_s13258_023_01391_9 crossref_primary_10_1016_j_diabres_2020_108027 crossref_primary_10_1038_s41598_021_84577_z crossref_primary_10_1038_oby_2010_236 crossref_primary_10_1186_s12967_015_0762_z crossref_primary_10_1148_radiol_12110772 crossref_primary_10_1097_HJH_0b013e32830dfe4b crossref_primary_10_2337_dc11_s224 crossref_primary_10_1016_j_ddmec_2010_05_002 crossref_primary_10_1016_j_physbeh_2008_05_024 crossref_primary_10_1111_j_1440_1746_2011_07045_x crossref_primary_10_3390_ijms222011128 crossref_primary_10_1016_j_clinre_2021_101769 crossref_primary_10_1038_nrendo_2011_138 crossref_primary_10_1002_hep_22220 crossref_primary_10_1016_j_jhep_2013_05_044 crossref_primary_10_1155_2012_914938 crossref_primary_10_1161_CIRCULATIONAHA_111_067264 crossref_primary_10_1155_2020_9519625 crossref_primary_10_1371_journal_pone_0062561 crossref_primary_10_1016_j_clinre_2024_102461 crossref_primary_10_1139_cjpp_2019_0037 crossref_primary_10_1016_j_rvsc_2009_12_012 crossref_primary_10_1016_S1665_2681_19_31850_2 crossref_primary_10_1016_j_jhep_2017_12_001 crossref_primary_10_1111_cen_12105 crossref_primary_10_1021_acs_jafc_2c05676 crossref_primary_10_1155_2017_3912567 crossref_primary_10_1530_JOE_11_0406 crossref_primary_10_1038_nutd_2011_2 crossref_primary_10_5812_hepatmon_26818 crossref_primary_10_1007_s00125_016_3944_1 crossref_primary_10_1007_s11695_009_9806_x crossref_primary_10_1136_pgmj_2008_078014 crossref_primary_10_1007_s00535_012_0585_0 crossref_primary_10_1194_jlr_M046607 crossref_primary_10_18632_oncotarget_10915 crossref_primary_10_1007_s00125_009_1285_z crossref_primary_10_1111_jdi_12418 crossref_primary_10_1194_jlr_P054387 crossref_primary_10_1210_jc_2012_2081 crossref_primary_10_1111_liv_14650 crossref_primary_10_1111_j_1365_2362_2010_02372_x crossref_primary_10_1530_EC_18_0497 crossref_primary_10_1186_s12944_017_0537_z crossref_primary_10_2337_db18_0539 crossref_primary_10_4093_dmj_2020_0137 crossref_primary_10_1016_j_cbi_2014_05_003 crossref_primary_10_1038_oby_2010_86 crossref_primary_10_1097_MOL_0b013e328317cc42 crossref_primary_10_1186_s12967_015_0684_9 crossref_primary_10_1007_s10072_014_1798_1 crossref_primary_10_1097_MOL_0b013e328338ca61 crossref_primary_10_2147_CIA_S301741 crossref_primary_10_1007_s13410_022_01097_w crossref_primary_10_1590_0102_311xen090522 crossref_primary_10_1016_j_pnmrs_2013_04_001 crossref_primary_10_1016_j_jpsychores_2022_110785 crossref_primary_10_1111_jdi_12731 crossref_primary_10_1016_j_vph_2015_04_004 crossref_primary_10_1007_s00404_020_05696_y crossref_primary_10_5124_jkma_2012_55_10_1005 crossref_primary_10_1007_s40265_012_0004_0 crossref_primary_10_3390_metabo13070822 crossref_primary_10_1016_j_advnut_2023_08_005 crossref_primary_10_1016_j_jhep_2010_06_013 crossref_primary_10_1111_scs_12029 crossref_primary_10_3390_metabo12050431 crossref_primary_10_7570_jomes22021 crossref_primary_10_1007_s12170_014_0384_7 crossref_primary_10_1016_j_beem_2016_06_006 crossref_primary_10_1016_j_cca_2018_10_033 crossref_primary_10_1111_j_1464_5491_2009_02785_x crossref_primary_10_1016_j_ijsu_2014_12_028 crossref_primary_10_1186_s12882_024_03757_x crossref_primary_10_1371_journal_pone_0009997 crossref_primary_10_3748_wjg_v20_i28_9330 crossref_primary_10_1111_ijpo_232 crossref_primary_10_1210_er_2008_0024 crossref_primary_10_1016_j_numecd_2011_04_010 crossref_primary_10_1016_j_jceh_2018_06_011 crossref_primary_10_3390_ijms20010006 crossref_primary_10_1016_j_atherosclerosis_2011_03_013 crossref_primary_10_3350_cmh_2021_0178 crossref_primary_10_1016_j_cgh_2015_05_001 crossref_primary_10_1055_a_1491_5792 crossref_primary_10_1111_j_1478_3231_2008_01952_x crossref_primary_10_1016_j_dld_2017_08_030 crossref_primary_10_1007_s00394_015_1129_1 crossref_primary_10_1530_EJE_08_0900 crossref_primary_10_3109_01913123_2014_947010 crossref_primary_10_1055_a_1862_9088 crossref_primary_10_1161_JAHA_115_002258 crossref_primary_10_3350_cmh_2018_0037 crossref_primary_10_1042_CS20070311 crossref_primary_10_1097_MOL_0b013e3282f41b4f crossref_primary_10_1038_s41598_017_15232_9 crossref_primary_10_1517_14656566_2011_629188 crossref_primary_10_1002_hep_26183 crossref_primary_10_1016_j_clnu_2011_01_006 crossref_primary_10_1152_physrev_00033_2011 crossref_primary_10_1371_journal_pone_0160704 crossref_primary_10_1186_s40064_015_1049_9 crossref_primary_10_1016_j_cld_2013_09_014 crossref_primary_10_1007_s11427_015_4836_1 crossref_primary_10_1007_BF03165969 crossref_primary_10_1111_j_1365_2362_2011_02572_x crossref_primary_10_1038_pr_2016_3 crossref_primary_10_1038_srep15256 crossref_primary_10_1053_j_gastro_2009_06_005 crossref_primary_10_4158_EP12331_OR crossref_primary_10_1371_journal_pone_0127368 crossref_primary_10_1111_j_1751_2980_2008_00323_x crossref_primary_10_1038_nrgastro_2013_41 crossref_primary_10_3748_wjg_v22_i2_681 crossref_primary_10_1007_s11892_011_0190_2 crossref_primary_10_1007_s00125_009_1282_2 crossref_primary_10_11005_jbm_2017_24_4_223 crossref_primary_10_1152_ajpendo_90224_2008 crossref_primary_10_1210_er_2008_0009 crossref_primary_10_1161_JAHA_113_000297 crossref_primary_10_1007_s00330_023_10081_9 crossref_primary_10_1097_MOL_0b013e32831b7581 crossref_primary_10_14814_phy2_13386 crossref_primary_10_3389_fmed_2019_00202 crossref_primary_10_1002_hep_22940 crossref_primary_10_1016_j_ajcnut_2024_06_006 crossref_primary_10_1038_nrgastro_2017_109 crossref_primary_10_15171_mejdd_2017_56 |
Cites_doi | 10.2337/diabetes.49.5.749 10.7326/0003-4819-132-2-200001180-00004 10.1161/01.ATV.0000148324.63685.6a 10.1016/S1043-2760(03)00078-X 10.2337/diab.26.1.22 10.1007/s00125-005-0125-z 10.1016/S0021-9673(01)89052-X 10.1093/ajcn/41.4.810 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 10.1101/gad.12.20.3168 10.1152/ajpendo.00117.2003 10.1046/j.1440-1746.2002.02846.x 10.1038/sj.ijo.0803189 10.1161/01.CIR.0000055014.62083.05 10.1152/ajpendo.00381.2004 10.3168/jds.S0022-0302(98)75630-9 10.2337/diabetes.53.8.2169 10.1080/07853890510037383 10.7326/0003-4819-137-1-200207020-00006 10.1111/j.1365-2265.2006.02543.x 10.1152/ajpendo.00064.2004 10.1016/S0140-6736(78)91595-7 10.1097/00002030-200211080-00011 10.1161/01.ATV.0000062885.61917.A5 10.1136/jech.45.2.131 10.1210/jc.2004-2479 10.1038/oby.2002.118 10.1016/S0022-2275(20)38029-9 10.1016/0730-725X(94)92543-7 10.1002/hep.20149 10.7326/0003-4819-143-10-200511150-00009 10.2337/diab.33.5.486 10.1210/jcem.87.7.8638 10.1172/JCI21047 10.1007/s00125-004-1460-1 10.1093/clinchem/18.6.499 10.1093/clinchem/14.2.116 |
ContentType | Journal Article |
Copyright | Copyright © 2007 by The Endocrine Society 2007 2007 INIST-CNRS Copyright © 2007 by The Endocrine Society |
Copyright_xml | – notice: Copyright © 2007 by The Endocrine Society 2007 – notice: 2007 INIST-CNRS – notice: Copyright © 2007 by The Endocrine Society |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QP 7T5 7TM H94 K9. 7X8 |
DOI | 10.1210/jc.2007-0482 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Immunology Abstracts Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Calcium & Calcified Tissue Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1945-7197 |
EndPage | 3497 |
ExternalDocumentID | 17595248 19081800 10_1210_jc_2007_0482 10.1210/jc.2007-0482 |
Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GroupedDBID | --- -~X .55 .XZ 08P 0R~ 18M 1TH 2WC 34G 354 39C 4.4 48X 53G 5GY 5RS 5YH 8F7 AABZA AACZT AAIMJ AAPQZ AAPXW AARHZ AAUAY AAVAP AAWTL ABBLC ABDFA ABEJV ABGNP ABJNI ABLJU ABMNT ABNHQ ABOCM ABPMR ABPPZ ABPQP ABPTD ABQNK ABVGC ABWST ABXVV ACGFO ACGFS ACPRK ACUTJ ACYHN ADBBV ADGKP ADGZP ADHKW ADQBN ADRTK ADVEK AELWJ AEMDU AENEX AENZO AERZD AETBJ AEWNT AFCHL AFFNX AFFZL AFGWE AFOFC AFRAH AFXAL AGINJ AGKRT AGQXC AGUTN AHMBA AHMMS AJEEA ALMA_UNASSIGNED_HOLDINGS APIBT ARIXL ASPBG ATGXG AVWKF AZFZN BAWUL BAYMD BCRHZ BEYMZ BSWAC BTRTY C45 CDBKE CS3 DAKXR DIK E3Z EBS EJD EMOBN ENERS F5P FECEO FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 HZ~ H~9 J5H KBUDW KOP KQ8 KSI KSN L7B M5~ MHKGH MJL N4W N9A NLBLG NOMLY NOYVH NVLIB O9- OAUYM OBH OCB ODMLO OFXIZ OGEVE OHH OJZSN OK1 OPAEJ OVD OVIDX P2P P6G REU ROX ROZ TEORI TJX TLC TR2 TWZ VVN W8F WOQ X7M YBU YFH YHG YOC YSK ZY1 ~02 ~H1 AAYXX ABXZS ADNBA AEHZK AEMQT AEOTA AFYAG ALXQX CITATION NU- .GJ 29K 3O- 7X7 88E 8FI 8FJ AAJQQ AAKAS AAPGJ AAQQT AAUQX AAWDT AAYJJ ABDPE ABUWG ACFRR ACVCV ACZBC ADMTO ADZCM AFFQV AFKRA AGMDO AGORE AHGBF AI. AJBYB AJDVS APJGH AQDSO AQKUS AVNTJ BENPR BPHCQ BVXVI CCPQU D-I EIHJH FEDTE FYUFA HMCUK HVGLF IAO IHR INH IQODW ITC M1P MBLQV OBFPC PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO TMA UKHRP VH1 WHG X52 ZGI ZXP 3V. CGR CUY CVF ECM EIF NPM VXZ 7QP 7T5 7TM H94 K9. 7X8 |
ID | FETCH-LOGICAL-c379t-70466f00c8a940c529949aa6d005eaa3d2b82b66e9282d4e717bf102a46b261f3 |
ISSN | 0021-972X |
IngestDate | Mon Sep 08 13:57:51 EDT 2025 Fri Sep 19 20:52:16 EDT 2025 Wed Feb 19 01:40:54 EST 2025 Mon Jul 21 09:13:52 EDT 2025 Thu Apr 24 23:03:39 EDT 2025 Wed Oct 01 04:41:30 EDT 2025 Fri Feb 07 10:35:43 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | Endocrinopathy Obesity Nutrition Digestive system X Syndrome Liver Nutrition disorder Fat Cardiovascular disease Metabolic diseases Endocrinology Nutritional status |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c379t-70466f00c8a940c529949aa6d005eaa3d2b82b66e9282d4e717bf102a46b261f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
PMID | 17595248 |
PQID | 3164416402 |
PQPubID | 2046206 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_68246508 proquest_journals_3164416402 pubmed_primary_17595248 pascalfrancis_primary_19081800 crossref_citationtrail_10_1210_jc_2007_0482 crossref_primary_10_1210_jc_2007_0482 oup_primary_10_1210_jc_2007-0482 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2007-09-01 |
PublicationDateYYYYMMDD | 2007-09-01 |
PublicationDate_xml | – month: 09 year: 2007 text: 2007-09-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Bethesda, MD |
PublicationPlace_xml | – name: Bethesda, MD – name: United States – name: Washington |
PublicationTitle | The journal of clinical endocrinology and metabolism |
PublicationTitleAlternate | J Clin Endocrinol Metab |
PublicationYear | 2007 |
Publisher | Oxford University Press Endocrine Society |
Publisher_xml | – name: Oxford University Press – name: Endocrine Society |
References | Hamaguchi ( key 2019041113575174100_R15) 2005; 143 Alberti ( key 2019041113575174100_R1) 2005 Yki-Jarvinen ( key 2019041113575174100_R2) 2005; 37 Lehti ( key 2019041113575174100_R35) 1971 Stranges ( key 2019041113575174100_R37) 2004; 39 Kuzuya ( key 2019041113575174100_R25) 1977; 26 Tiikkainen ( key 2019041113575174100_R10) 2002; 10 Nikkila ( key 2019041113575174100_R31) 1978; 2 Miles ( key 2019041113575174100_R28) 1983; 24 Ridker ( key 2019041113575174100_R8) 2003; 107 Sutinen ( key 2019041113575174100_R22) 2002; 16 Omagari ( key 2019041113575174100_R33) 2002; 17 Kerner ( key 2019041113575174100_R6) 2005; 25 Santoliquido ( key 2019041113575174100_R18) 2005; 9 Strang ( key 2019041113575174100_R39) 1998; 81 Thomsen ( key 2019041113575174100_R20) 1994; 12 Moitra ( key 2019041113575174100_R11) 1998; 12 Prati ( key 2019041113575174100_R34) 2002; 137 Yki-Jarvinen ( key 2019041113575174100_R7) 2003; 23 Mertens ( key 2019041113575174100_R9) 2006; 30 Kelley ( key 2019041113575174100_R16) 2003; 285 Agarwal ( key 2019041113575174100_R12) 2003; 14 Kadish ( key 2019041113575174100_R24) 1968; 14 Stenman ( key 2019041113575174100_R26) 1984; 297 Szczepaniak ( key 2019041113575174100_R29) 2005; 288 Marti ( key 2019041113575174100_R23) 1991; 45 Friedewald ( key 2019041113575174100_R27) 1972; 18 Adiels ( key 2019041113575174100_R5) 2006; 49 Stefan ( key 2019041113575174100_R14) 2005; 90 Ryysy ( key 2019041113575174100_R4) 2000; 49 Polonsky ( key 2019041113575174100_R41) 1984; 33 Alberti ( key 2019041113575174100_R42) 1998; 15 Westerbacka ( key 2019041113575174100_R13) 2004; 47 Bellentani ( key 2019041113575174100_R17) 2000; 132 Armitage ( key 2019041113575174100_R32) 1966; 30 Seppala-Lindroos ( key 2019041113575174100_R3) 2002; 87 Lukaski ( key 2019041113575174100_R21) 1985; 41 Pietilainen ( key 2019041113575174100_R19) 2005; 288 Tiikkainen ( key 2019041113575174100_R40) 2004; 53 Nielsen ( key 2019041113575174100_R30) 2004; 113 McKenzie ( key 2019041113575174100_R36) 2006; 65 Goto ( key 2019041113575174100_R38) 1995; 19 |
References_xml | – volume: 49 start-page: 749 year: 2000 ident: key 2019041113575174100_R4 article-title: Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. publication-title: Diabetes doi: 10.2337/diabetes.49.5.749 – volume: 132 start-page: 112 year: 2000 ident: key 2019041113575174100_R17 article-title: Prevalence of and risk factors for hepatic steatosis in northern Italy. publication-title: Ann Intern Med doi: 10.7326/0003-4819-132-2-200001180-00004 – volume: 25 start-page: 193 year: 2005 ident: key 2019041113575174100_R6 article-title: Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.0000148324.63685.6a – volume: 14 start-page: 214 year: 2003 ident: key 2019041113575174100_R12 article-title: Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways. publication-title: Trends Endocrinol Metab doi: 10.1016/S1043-2760(03)00078-X – volume: 26 start-page: 22 year: 1977 ident: key 2019041113575174100_R25 article-title: Determination of free and total insulin and C-peptide in insulin-treated diabetics. publication-title: Diabetes doi: 10.2337/diab.26.1.22 – volume: 49 start-page: 755 year: 2006 ident: key 2019041113575174100_R5 article-title: Overproduction of large VLDL particles is driven by increased liver fat content in man. publication-title: Diabetologia doi: 10.1007/s00125-005-0125-z – volume: 297 start-page: 327 year: 1984 ident: key 2019041113575174100_R26 article-title: Rapid chromatographic quantitation of glycosylated haemoglobins. publication-title: J Chromatogr doi: 10.1016/S0021-9673(01)89052-X – year: 1971 ident: key 2019041113575174100_R35 – volume: 41 start-page: 810 year: 1985 ident: key 2019041113575174100_R21 article-title: Assessment of fat-free mass using bioelectrical impedance measurements of the human body. publication-title: Am J Clin Nutr doi: 10.1093/ajcn/41.4.810 – volume: 15 start-page: 539 year: 1998 ident: key 2019041113575174100_R42 article-title: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. publication-title: Diabet Med doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S – volume: 12 start-page: 3168 year: 1998 ident: key 2019041113575174100_R11 article-title: Life without white fat: a transgenic mouse. publication-title: Genes Dev doi: 10.1101/gad.12.20.3168 – volume: 285 start-page: E906 year: 2003 ident: key 2019041113575174100_R16 article-title: Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00117.2003 – volume: 17 start-page: 1098 year: 2002 ident: key 2019041113575174100_R33 article-title: Fatty liver in non-alcoholic non-overweight Japanese adults: Incidence and clinical characteristics. publication-title: J Gastroenterol Hepatol doi: 10.1046/j.1440-1746.2002.02846.x – volume: 19 start-page: 841 year: 1995 ident: key 2019041113575174100_R38 article-title: The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. publication-title: Int J Obes Relat Metab Disord – volume: 30 start-page: 1308 year: 2006 ident: key 2019041113575174100_R9 article-title: Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome. publication-title: Int J Obes (Lond) doi: 10.1038/sj.ijo.0803189 – volume: 107 start-page: 391 year: 2003 ident: key 2019041113575174100_R8 article-title: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14,719 initially healthy American women. publication-title: Circulation doi: 10.1161/01.CIR.0000055014.62083.05 – volume: 288 start-page: E768 year: 2005 ident: key 2019041113575174100_R19 article-title: Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00381.2004 – volume: 81 start-page: 740 year: 1998 ident: key 2019041113575174100_R39 article-title: Relationship of triglyceride accumulation to insulin clearance and hormonal responsiveness in bovine hepatocytes. publication-title: J Dairy Sci doi: 10.3168/jds.S0022-0302(98)75630-9 – volume: 53 start-page: 2169 year: 2004 ident: key 2019041113575174100_R40 article-title: Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. publication-title: Diabetes doi: 10.2337/diabetes.53.8.2169 – volume: 37 start-page: 347 year: 2005 ident: key 2019041113575174100_R2 article-title: Fat in the liver and insulin resistance. publication-title: Ann Med doi: 10.1080/07853890510037383 – volume: 137 start-page: 1 year: 2002 ident: key 2019041113575174100_R34 article-title: Updated definitions of healthy ranges for serum alanine aminotransferase levels. publication-title: Ann Intern Med doi: 10.7326/0003-4819-137-1-200207020-00006 – volume: 65 start-page: 40 year: 2006 ident: key 2019041113575174100_R36 article-title: Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. publication-title: Clin Endocrinol (Oxf) doi: 10.1111/j.1365-2265.2006.02543.x – volume: 288 start-page: E462 year: 2005 ident: key 2019041113575174100_R29 article-title: Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00064.2004 – volume: 2 start-page: 892 year: 1978 ident: key 2019041113575174100_R31 article-title: Relation between H.D.L.-cholesterol levels and triglyceride metabolism publication-title: Lancet doi: 10.1016/S0140-6736(78)91595-7 – volume: 16 start-page: 2183 year: 2002 ident: key 2019041113575174100_R22 article-title: Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy. publication-title: AIDS doi: 10.1097/00002030-200211080-00011 – volume: 30 start-page: 337 year: 1966 ident: key 2019041113575174100_R32 article-title: The variability of measurements of casual blood pressure. II. Survey experience. publication-title: Clin Sci – volume: 23 start-page: 688 year: 2003 ident: key 2019041113575174100_R7 article-title: Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy. publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.0000062885.61917.A5 – volume: 45 start-page: 131 year: 1991 ident: key 2019041113575174100_R23 article-title: Body fat distribution in the Finnish population: environmental determinants and predictive power for cardiovascular risk factor levels. publication-title: J Epidemiol Community Health doi: 10.1136/jech.45.2.131 – volume: 90 start-page: 4238 year: 2005 ident: key 2019041113575174100_R14 article-title: Liver fat and insulin resistance are independently associated with the −514C>T polymorphism of the hepatic lipase gene. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2004-2479 – volume: 10 start-page: 859 year: 2002 ident: key 2019041113575174100_R10 article-title: Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. publication-title: Obes Res doi: 10.1038/oby.2002.118 – volume: 9 start-page: 269 year: 2005 ident: key 2019041113575174100_R18 article-title: Hepatic steatosis and vascular disease. publication-title: Eur Rev Med Pharmacol Sci – volume: 24 start-page: 96 year: 1983 ident: key 2019041113575174100_R28 article-title: A microfluorometric method for the determination of free fatty acids in plasma. publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)38029-9 – volume: 12 start-page: 487 year: 1994 ident: key 2019041113575174100_R20 article-title: Quantification of liver fat using magnetic resonance spectroscopy. publication-title: Magn Reson Imaging doi: 10.1016/0730-725X(94)92543-7 – volume: 39 start-page: 754 year: 2004 ident: key 2019041113575174100_R37 article-title: Body fat distribution, relative weight, and liver enzyme levels: a population-based study. publication-title: Hepatology doi: 10.1002/hep.20149 – volume: 143 start-page: 722 year: 2005 ident: key 2019041113575174100_R15 article-title: The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. publication-title: Ann Intern Med doi: 10.7326/0003-4819-143-10-200511150-00009 – volume: 33 start-page: 486 year: 1984 ident: key 2019041113575174100_R41 article-title: C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. publication-title: Diabetes doi: 10.2337/diab.33.5.486 – start-page: 1059 volume-title: Lancet year: 2005 ident: key 2019041113575174100_R1 article-title: The metabolic syndrome—a new worldwide definition. – volume: 87 start-page: 3023 year: 2002 ident: key 2019041113575174100_R3 article-title: Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem.87.7.8638 – volume: 113 start-page: 1582 year: 2004 ident: key 2019041113575174100_R30 article-title: Splanchnic lipolysis in human obesity. publication-title: J Clin Invest doi: 10.1172/JCI21047 – volume: 47 start-page: 1360 year: 2004 ident: key 2019041113575174100_R13 article-title: Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. publication-title: Diabetologia doi: 10.1007/s00125-004-1460-1 – volume: 18 start-page: 499 year: 1972 ident: key 2019041113575174100_R27 article-title: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. publication-title: Clin Chem doi: 10.1093/clinchem/18.6.499 – volume: 14 start-page: 116 year: 1968 ident: key 2019041113575174100_R24 article-title: A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. publication-title: Clin Chem doi: 10.1093/clinchem/14.2.116 |
SSID | ssj0014453 |
Score | 2.4358723 |
Snippet | Background: The liver, once fatty, overproduces components of the metabolic syndrome, such as glucose and lipids. The amount of liver fat in subjects with and... The liver, once fatty, overproduces components of the metabolic syndrome, such as glucose and lipids. The amount of liver fat in subjects with and without the... |
SourceID | proquest pubmed pascalfrancis crossref oup |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 3490 |
SubjectTerms | Abdominal Fat - anatomy & histology Adult Aged Alanine transaminase Aspartate aminotransferase Biological and medical sciences Body Composition Body mass index C-Peptide - blood Diabetes mellitus Endocrinopathies Feeding. Feeding behavior Female Fundamental and applied biological sciences. Psychology Gender Humans Insulin Insulin resistance Lipid metabolism Lipids - analysis Liver Liver - chemistry Liver - enzymology Magnetic resonance imaging Magnetic resonance spectroscopy Male Medical sciences Metabolic syndrome Metabolic Syndrome - blood Metabolic Syndrome - diagnostic imaging Metabolic Syndrome - etiology Middle Aged Peptides Radiography Sex Characteristics Vertebrates: anatomy and physiology, studies on body, several organs or systems Vertebrates: endocrinology Women |
Title | Liver Fat in the Metabolic Syndrome |
URI | https://www.ncbi.nlm.nih.gov/pubmed/17595248 https://www.proquest.com/docview/3164416402 https://www.proquest.com/docview/68246508 |
Volume | 92 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1945-7197 dateEnd: 20241003 omitProxy: true ssIdentifier: ssj0014453 issn: 0021-972X databaseCode: DIK dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: Geneva Foundation for Medical Education and Research Open Access Journals customDbUrl: eissn: 1945-7197 dateEnd: 20241003 omitProxy: true ssIdentifier: ssj0014453 issn: 0021-972X databaseCode: GX1 dateStart: 19960101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBASQtwpjBEJeJqCcnHs5LFMZS1rV2l0Ut8i23EkGKQTTV_49ZwTO06GWnF5idLEdSKfk8_ns8-FkLeAcDosFPeZDkNMqk19mQjmgy0Q6pTBnN7UBpyfs8kl_bRKVoPBth9dUsv36ufOuJL_kSpcA7lilOw_SNZ1ChfgHOQLR5AwHP9KxjN0qjguRd16K37XNQgV81bvykSAKtHLFOGCInVVrAE8qi4dU9uPTS-IgLxYXizOx8YpoKo6MB9_BoP4w-jkbGSCPK6uOoo_vjidLGbzzoPbAfF0vJzOcJM-pVPb6xmun9hYiXYZgjs_K7s2Zt9Ut96mfdBFLxDeVE13oJtFPeXKeggaU1M-1M7G8JPvRHqgqoj0JgulDzgUdTNau4v_20Tn3A_BCMIQ9-AWuR1xxrDwxenKeQYBxbTJS-1723gJDHbqP--GJWOiI-9diw3IrTQ1UfaTlsZ4WT4g9y3r8EZGhR6Sga4ekTtz61fxmLxpNMkDTfK-VB5okuc0yWs16Qm5_Dhenkx8Wz7DVzHPap8HlLEyCFQqMhqoBD5LmgnBCgBeLURcRDKNJGM6A9pdUA3EXpZgbwrKJPDqMn5KDqp1pZ8TTwValFIzypmiOisknMkgAqpf8FCpdEiO26HIlc0tjyVOvuXIMWHg8q8KC57yHAduSN651tcmp8qedh6M6r4mvmlydGPIu8ZWxENy2Mogt1_YJo9DZAGMBvD_1-424CpulolKr7ebnKURRfYyJM-M5LqueZIlEU1f_OnZL8nd7ks5JAf1j61-BSZsLY8ahfsFQhyT0Q |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Liver+fat+in+the+metabolic+syndrome&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=KOTRONEN%2C+Anna&rft.au=WESTERBACKA%2C+Jukka&rft.au=BERGHOLM%2C+Robert&rft.au=PIETIL%C3%84INEN%2C+Kirsi+H&rft.date=2007-09-01&rft.pub=Endocrine+Society&rft.issn=0021-972X&rft.volume=92&rft.issue=9&rft.spage=3490&rft.epage=3497&rft_id=info:doi/10.1210%2Fjc.2007-0482&rft.externalDBID=n%2Fa&rft.externalDocID=19081800 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon |